The retail giant did not have its best month of trading…
The post Here’s what happened to the Wesfarmers (ASX:WES) share price in September appeared first on The Motley Fool Australia. –
The Wesfarmers Ltd (ASX: WES) share price had… an interesting September. Not that that was anything different to what the broader S&P/ASX 200 Index (ASX: XJO) experienced over the month that was. The ASX 200 ended up losing roughly 2.6% of its value over September.
But how did Wesfarmers do? After all, Wesfarmers is one of the bluest ASX 200 blue chips on the markets and is a major constituent of the ASX 200 itself.
So the Wesfarmers share price started the month off at $59.95 a share. It ended September at the price of $55.75. That means Wesfarmers shares went backwards by exactly 7% over the month.
That’s a pretty large number for one month’s efforts. Especially if you consider it’s a loss almost 3 times greater than the ASX 200’s. So what happened here?
September rains on ASX 200 parade
Well, it’s worth pointing out that Wesfarmers went ex-dividend for its upcoming final dividend payment on 1 September. Wesfarmers will be shelling out a final dividned of 90 cents per share, fully franked, on 8 October. When the company traded ex-dividend on 1 September, it gave the Wesfarmers share price more than just a pinch and a punch.
As we covered at the time, this initially sent Wesfarmers shares down as much as 3%. This is quite normal for a share trading ex-dividend with the value of the dividend leaving the share price as new investors aren’t entitled to the payout. Even so, it still contributed to Wesfarmers’ poor performance over the month.
Another factor that could have turned investors off Wesfarmers is the long-running battle to takeover Australian Pharmaceutical Industries Ltd (ASX: API). API is the company behind the Priceline chain of pharmacy stores.
Wesfarmers has lobbed more than one bid for API. Its most recent offer came in mid-September when the company offered up $1.55 for every API share on the market. It’s previous offer was valued at $1.38.
However, we learned last month that Sigma Healthcare Ltd (ASX: SIG) had also thrown its hat into the ring, putting up an offer worth $1.57 a share. As it stands today, there is no sign who will end up winning the bidding war. Although Wesfarmers has yet to top the offer Sigma has on the table. Perhaps this dampened investor enthusiasm for Wesfarmers shares in the back half of September.
About the Wesfarmers share price
Although September was a tough month for Wesfarmers, the picture looks more pleasing if we zoom out a little. The company is still up 6.25% year to date in 2021 so far and is also up by close to 22% over the past year.
Should you invest $1,000 in Wesfarmers right now?
Before you consider Wesfarmers, you’ll want to hear this.
Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Wesfarmers wasn’t one of them.
The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.
*Returns as of August 16th 2021
Motley Fool contributor Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Wesfarmers Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.